TrialCancer2014
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
Heikki Joensuu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled ittrialcites it